本月全球药品研发进展取得成效的药物有31个,较上月减少了1个。进入注册阶段的有10个,比上月大幅减少11个。其中3个为全球首次注册的新活性物质和新制剂,7个为在新市场补充注册。本月全球首次注册的药物为3个,其中1个新活性物质,是由Amgen公司研发的内分泌及代谢调节 There were 31 drugs that made progress in global drug development this month, down 1 month from the previous month. There were 10 registrations, a sharp decrease of 11 from the previous month. Three of them were the first new active substances and new preparations registered in the world and seven were newly registered in the new markets. This month the world’s first drug registration for the three, including a new active substance, developed by the company Amgen endocrine and metabolic regulation